AbCellera Biologics OverviewAbCellera Biologics Net Income
Profitability analysis for ABCL.
Quarterly Net Income
-$43.16M
↑ 5.38% YoY
As of Mar 2026
Annual Net Income (TTM)
-$143.96M
↑ 14.24% YoY
Trailing 12 months ending Mar 2026
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...